Zheng Q - Search Results

1

Randomised, double-blind, multicentre, phase Ⅰ/Ⅱ dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol.

Dong W, Nie X, Wang J, Xia L, Cai L, Wang Q, Wang W, Fu W, Wang Q, Shen T, Fan H, Niu S, Cui Y, Zheng Q, Zhang J, Fang Y. Dong W, et al. Among authors: zheng q. BMJ Open. 2020 Nov 24;10(11):e039067. doi: 10.1136/bmjopen-2020-039067. BMJ Open. 2020. PMID: 33234634 Free PMC article.

2

Population pharmacokinetics and pharmacodynamics of bivalirudin in young healthy Chinese volunteers.

Zhang DM, Wang K, Zhao X, Li YF, Zheng QS, Wang ZN, Cui YM. Zhang DM, et al. Acta Pharmacol Sin. 2012 Nov;33(11):1387-94. doi: 10.1038/aps.2012.37. Epub 2012 Jun 4. Acta Pharmacol Sin. 2012. PMID: 22659624 Free PMC article. Clinical Trial.

3

ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial.

Jiang W, Yu X, Sun T, Chai Y, Chang P, Chen Z, Pan J, Peng Z, Wang R, Wang X, Xu Y, Yu L, Zheng Q, Du B; China Critical Care Clinical Trials Group (CCCCTG). Jiang W, et al. Among authors: zheng q. Trials. 2018 Feb 21;19(1):133. doi: 10.1186/s13063-018-2513-y. Trials. 2018. PMID: 29467017 Free PMC article.

4

A dose-finding study for hemoporfin in photodynamic therapy for port-wine stain: A multicenter randomized double-blind phase IIb trial.

Wu Q, Tu P, Zhou G, Yang H, Zhou Z, Zhao Y, Zheng Q, Gu Y, Tao J, Zhu X. Wu Q, et al. Among authors: zheng q. Photodermatol Photoimmunol Photomed. 2018 Sep;34(5):314-321. doi: 10.1111/phpp.12384. Epub 2018 Apr 22. Photodermatol Photoimmunol Photomed. 2018. PMID: 29533491 Clinical Trial.

5

A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects.

Zhang T, Chen G, Liu C, Zu L, Wang Q, Wang Y, Lv J, An Y, Dong L, Cheng H, Ren S, Wang Q, Zheng Q, Song H, Fang Y. Zhang T, et al. Among authors: zheng q. BioDrugs. 2019 Feb;33(1):93-100. doi: 10.1007/s40259-018-0326-x. BioDrugs. 2019. PMID: 30511316 Clinical Trial.

6

A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults.

Wang J, Niu S, Dong W, Wei L, Ou L, Zhang T, Zhang L, Nie X, Wang Q, Shen T, Wang Q, Xia L, Liu G, Jin J, Zheng Q, Song H, Fang Y. Wang J, et al. Among authors: zheng q. Expert Opin Investig Drugs. 2020 Jul;29(7):755-762. doi: 10.1080/13543784.2020.1770226. Epub 2020 Jun 27. Expert Opin Investig Drugs. 2020. PMID: 32594779 Clinical Trial.

7

A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis.

Cai L, Chen GH, Lu QJ, Zheng M, Li YZ, Chen J, Zheng J, Zhang FR, Yu JB, Yang S, Li FQ, Xiao SX, Sun QN, Xu JH, Gao XH, Fang H, Gao TW, Hao F, Liu QZ, Tu YT, Li RY, Wang BX, Deng DQ, Zheng QS, Liu HX, Zhang JZ. Cai L, et al. Chin Med J (Engl). 2020 Nov 9;133(24):2905-2909. doi: 10.1097/CM9.0000000000001221. Chin Med J (Engl). 2020. PMID: 33177393 Free PMC article. Clinical Trial.

8

Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial.

Dong W, Chen M, Niu S, Wang B, Xia L, Wang J, Shen T, Wang Q, Lv J, Liu G, Fan H, Xie Z, Xie F, An Y, Zheng Q, Rao H, Song H, Fang Y. Dong W, et al. Among authors: zheng q. Expert Opin Biol Ther. 2022 Feb;22(2):253-262. doi: 10.1080/14712598.2021.1954157. Epub 2021 Jul 26. Expert Opin Biol Ther. 2022. PMID: 34236011 Clinical Trial.

9

The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial.

Huang J, Yu Y, Jiang Y, Chen W, Li Y, Shen Y, Zheng Q, Li H. Huang J, et al. Among authors: zheng q. Trials. 2021 Sep 3;22(1):585. doi: 10.1186/s13063-021-05550-9. Trials. 2021. PMID: 34479619 Free PMC article.

10

Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis.

Zhang L, Gan L, Li K, Xie P, Tan Y, Wei G, Yuan X, Pratt R, Zhou Y, Hui AM, Fang Y, Zuo L, Zheng Q. Zhang L, et al. Among authors: zheng q. Eur J Clin Pharmacol. 2022 Sep;78(9):1421-1434. doi: 10.1007/s00228-022-03328-9. Epub 2022 Jun 17. Eur J Clin Pharmacol. 2022. PMID: 35711066 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,676 results

Search Page

Filters